Table 2.
Association between rs10505477 polymorphism and overall survival of gastric cancer.
| Genetic Model | Genotypes | Patients | Deaths | MST (Months) | log-Rank p | HR (95% CI) * |
|---|---|---|---|---|---|---|
| Codominant model | GG | 315 | 136 | 77 | 0.185 | 1.000 |
| GA | 434 | 215 | 60 | 1.200 (0.968–1.488) | ||
| AA | 160 | 67 | 69 | 1.014 (0.757–1.359) | ||
| Dominant model | GG | 315 | 136 | 77 | 0.177 | 1.000 |
| GA/AA | 594 | 282 | 63 | 1.150 (0.937–1.411) | ||
| Recessive model | GG/GA | 749 | 351 | 67 | 0.478 | 1.000 |
| AA | 160 | 67 | N/A1 | 0.910 (0.701–1.182) |
Abbreviations: MST, median survival time; HR, hazard ratio; CI, confidence interval; * Hazard Ratio (HR) adjusted for age, sex, Tumor, Node and Metastasis (TNM) stage; N/A1, Mean the median survival time could not be measured.